R1 and Palantir Technologies Inc (NASDAQ: PLTR) have partnered to create R37, an AI lab aimed at revolutionizing healthcare reimbursement processes. By combining R1's expertise in revenue cycle management and Palantir's AI tools,

Key Takeaways Palantir shares tumbled Monday, extending losses over the past month.The artificial intelligence analytics company's stock has lost almost 40% of its value since closing at a record high on Feb.

Shares of data-mining and analytics company Palantir (NYSE:PLTR) jumped 7% in the pre-market session after the company revealed new commercial customers, including Walgreens Boots Alliance and Heineken.

Palantir shares broke through the psychologically significant $80.00 level to finish trading at $76.38 for the day. The stock has been able to trade in a consolidation pattern between 80 and $90.00 for much of the last two weeks, while the rest of the market has declined.

Palantir Technologies stock was rising Wednesday. The analytics software developer revealed a slate of new customers late Tuesday, which could be giving it a much-needed boost. Shares climbed 6.8% to $83.

Shares of Palantir Technologies ( PLTR -11.35%) are plummeting on Monday. The company's stock lost 11.1% as of 2:20 p.m. ET and was down as much as 12% earlier in the day. The drop comes amid broader market weakness,

Palantir (PLTR) has been in a freefall over the past three weeks amidst concerns that President Donald Trump’s tariffs could lead to stickier inflation and an economic slowdown in 2025. Plus, Trump’s administration announced plans to lower defense spending last month that also did not bode well for PLTR shares.